<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Hazardous Drugs: NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 and Final Reevaluation Determinations for Liraglutide and Pertuzumab</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Hazardous Drugs: NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 and Final Reevaluation Determinations for Liraglutide and Pertuzumab</h1>
    <p class="timestamp">Published: 2024-12-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the publication of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024, as well as final reevaluation determinations removing the drugs liraglutide and pertuzumab from the NIOSH List of Hazardous Drugs in Healthcare Settings.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Centers for Disease Control and Prevention</p>
    <p><strong>Document Number:</strong> 2024-30456</p>
    <p><strong>Publication Date:</strong> 2024-12-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2024/12/20/2024-30456/hazardous-drugs-niosh-list-of-hazardous-drugs-in-healthcare-settings-2024-and-final-reevaluation">https://www.federalregister.gov/documents/2024/12/20/2024-30456/hazardous-drugs-niosh-list-of-hazardous-drugs-in-healthcare-settings-2024-and-final-reevaluation</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2024-30456</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
